Hepatoviruses promote very-long-chain fatty acid and sphingolipid synthesis for viral RNA replication and quasi-enveloped virus release
Science Advances · 2023
DOI: 10.1126/sciadv.adj4198 ↗Kurz gefasst
Fachartikel in der Zeitschrift Science Advances, 2023. Verfasst von Tomoyuki Shiota und 14 weiteren Autor:innen. Beteiligte Einrichtung: Lineberger Comprehensive Cancer Center, The University of North Carolina at Chapel Hill, Chapel Hill, NC, USA. Hauptthemen laut MEDLINE: Hepatovirus, RNA, Viral. Die Arbeit wurde bisher 24-mal zitiert (Crossref) und nennt 65 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NIDDK NIH HHS, NCI NIH HHS, NIAID NIH HHS.
Abstract (Originalsprache)
Virus-induced changes in host lipid metabolism are an important but poorly understood aspect of viral pathogenesis. By combining nontargeted lipidomics analyses of infected cells and purified extracellular quasi-enveloped virions with high-throughput RNA sequencing and genetic depletion studies, we show that hepatitis A virus, an hepatotropic picornavirus, broadly manipulates the host cell lipid environment, enhancing synthesis of ceramides and other sphingolipids and transcriptionally activating acyl–coenzyme A synthetases and fatty acid elongases to import and activate long-chain fatty acids for entry into the fatty acid elongation cycle. Phospholipids with very-long-chain acyl tails (>C22) are essential for genome replication, whereas increases in sphingolipids support assembly and release of quasi-enveloped virions wrapped in membranes highly enriched for sphingomyelin and very-long-chain ceramides. Our data provide insight into how a pathogenic virus alters lipid flux in infected hepatocytes and demonstrate a distinction between lipid species required for viral RNA synthesis versus nonlytic quasi-enveloped virus release.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Lineberger Comprehensive Cancer Center, The University of North Carolina at Chapel Hill, Chapel Hill, NC, USA.
- Center for Translational Biomedical Research, The University of North Carolina at Greensboro, Kannapolis, NC, USA.
- Department of Microbiology and Immunology, The University of North Carolina at Chapel Hill, Chapel Hill, NC, USA.
- Department of Epidemiology, The University of North Carolina at Chapel Hill, Chapel Hill, NC, USA.
- Department of Infectious Disease Research, Foundation for Biomedical Research and Innovation at Kobe, Kobe, Hyogo, Japan.
- Department of Cell Biology and Physiology, The University of North Carolina at Chapel Hill, Chapel Hill, NC, USA.
ORCID-Profile: Tomoyuki Shiota, Zhucui Li, Guan-Yuan Chen, Kevin L McKnight, Heyjeong Kim, Ethan J Fritch, Timothy P Sheahan, Maryna Kapustina, Qibin Zhang, Stanley M Lemon
Förderung
- NIDDK NIH HHS
- NCI NIH HHS
- NIAID NIH HHS
Zitieren
APA
Shiota, T., Li, Z., Chen, G. Y., McKnight, K. L., Shirasaki, T., Yonish, B., Kim, H., Fritch, E. J., Sheahan, T. P., Muramatsu, M., Kapustina, M., Cameron, C. E., Li, Y., Zhang, Q., & Lemon, S. M. (2023). Hepatoviruses promote very-long-chain fatty acid and sphingolipid synthesis for viral RNA replication and quasi-enveloped virus release. Science Advances. https://doi.org/10.1126/sciadv.adj4198
Vancouver
Shiota T, Li Z, Chen GY, McKnight KL, Shirasaki T, Yonish B, et al. Hepatoviruses promote very-long-chain fatty acid and sphingolipid synthesis for viral RNA replication and quasi-enveloped virus release. Science Advances. 2023. doi:10.1126/sciadv.adj4198
BibTeX
@article{Shiota2023,
author = {Shiota, Tomoyuki and Li, Zhucui and Chen, Guan-Yuan and McKnight, Kevin L and Shirasaki, Takayoshi and Yonish, Bryan and Kim, Heyjeong and Fritch, Ethan J and Sheahan, Timothy P and Muramatsu, Masamichi and Kapustina, Maryna and Cameron, Craig E and Li, You and Zhang, Qibin and Lemon, Stanley M},
title = {Hepatoviruses promote very-long-chain fatty acid and sphingolipid synthesis for viral RNA replication and quasi-enveloped virus release},
journal = {Science Advances},
year = {2023},
doi = {10.1126/sciadv.adj4198}
}
EUVIMED